GlassScriptPhysician profile
Sandra Lynn Gregory
NPI 1376503128
$131.34
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.03 · 2020: $28.53 · 2021: $49.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $43.99 | 2020-2021 | |
| Seagen INC. | $19.85 | 2021 | |
| Amgen INC. | $18.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.89 | 2019 | |
| Fortovia Therapeutics, INC. | $16.75 | 2019 | |
| Genzyme Corporation | $14.47 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.